SG/PUT/NOVO-NORDISK B/950/0.1/21.03.25 Share Price

Warrant

DE000SW7ZJN7

Market Closed - Boerse Frankfurt Warrants 01:16:33 06/07/2024 am IST
1.31 EUR -2.24% Intraday chart for SG/PUT/NOVO-NORDISK B/950/0.1/21.03.25
Current month+8.26%
1 month-4.38%
Date Price Change
05/24/05 1.31 -2.24%
04/24/04 1.34 -3.60%
03/24/03 1.39 +13.01%
02/24/02 1.23 +8.85%
01/24/01 1.13 -6.61%

Real-time Boerse Frankfurt Warrants

Last update July 06, 2024 at 01:16 am IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SW7ZJN
ISINDE000SW7ZJN7
Date issued 20/03/2024
Strike 950 kr
Maturity 21/03/2025 (259 Days)
Parity 10 : 1
Emission price 2.06
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 2.44
Lowest since issue 1.04
Delta0x
Omega 0.000000
Premium0x
Gearing9.85x
Moneyness 0.9754
Difference Strike -24 kr
Difference Strike %-2.53%
Spread 0.03
Spread %2.24%
Intrinsic value 0.000000
Present value 1.335

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
974 DKK
Average target price
952.2 DKK
Spread / Average Target
-2.24%
Consensus